The goal of this study was to investigate whether differences in the angiogenic factors sFlt1, sEng and PlGF in high-risk patients would identify women who later develop preeclampsia in a manner similar to reports in the literature regarding low-risk women. The gene discussed is PGF; the disease is preeclampsia.